RankingsPricing
  1. US-listed companies
  2. ABEONA THERAPEUTICS INC.
  3. Financials
  4. Return on Assets

ABEONA THERAPEUTICS INC.ABEO

Market cap
$248.11M
P/E ratio
SummaryFinancials
Period EndReturn on Assets (Million USD)YoY (%)
Dec 31, 2024-73.7-12.80%
Dec 31, 2023-84.5+53.11%
Dec 31, 2022-55.2-25.00%
Dec 31, 2021-73.6+63.65%
Dec 31, 2020-45+17.29%
Dec 31, 2019-38.3+19.51%
Dec 31, 2018-32.1+70.24%
Dec 31, 2017-18.8-17.65%
Dec 31, 2016-22.9-23.85%
Dec 31, 2015-30.1-90.35%
Dec 31, 2014-311.5-182.01%
Dec 31, 2013379.8-199.43%
Dec 31, 2012-381.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)